Cargando…
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
Since the approval of the first monoclonal antibody (mAb) in 1986, a huge effort has been made to guarantee safety and efficacy of therapeutic mAbs. As of July 2021, 118 mAbs are approved for the European market for a broad range of clinical indications. In order to ensure clinical efficacy and safe...
Autores principales: | Gogesch, Patricia, Dudek, Simone, van Zandbergen, Ger, Waibler, Zoe, Anzaghe, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396266/ https://www.ncbi.nlm.nih.gov/pubmed/34445651 http://dx.doi.org/10.3390/ijms22168947 |
Ejemplares similares
-
Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection
por: Niles, Marc A., et al.
Publicado: (2021) -
Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages
por: Arens, Katharina, et al.
Publicado: (2018) -
Nivolumab Enhances In Vitro Effector Functions of PD-1(+) T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner
por: Filippis, Christodoulos, et al.
Publicado: (2017) -
Complement protein C3a enhances adaptive immune responses towards FVIII products
por: Ringler, Eva, et al.
Publicado: (2023) -
Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies
por: Mata-Molanes, Juan J., et al.
Publicado: (2022)